Association for Molecular Pathology

✈️ We’re heading to #AMPath2025! Visit us at booth 1037 to learn how we’re bridging accuracy and accessibility in targeted #sequencing and clinical oncology research. Join our workshops on November 12 to see the Trinity™ workflow in action. https://bit.ly/4oKBstO

Social card for webinar series presented by AMP titled "Metastatic Breast Cancer Molecular Testing." This card is promoting the third webinar in the series, "Applying Molecular Testing in Practice with Case Discussions and Expert Panel" featuring speaker Karthik Giridhar.

Today is the final webinar in our series on molecular testing for HR+/HER- breast cancer. We'll show how specific genomic alterations (e.g., PIK3CA & ESR1 variants) can guide personalized treatment strategies and improve outcomes.

https://educate.amp.org/local/catalog/view/product.php?productid=577

Graphic has the official AMP 2025 logo and a drawing of both DNA and an empty bottle that could be used to hold biological samples.

The #AMPath2025 Reference Material Forum will cover the availability and development of genetic testing reference materials and identify gaps/needs for use in test validation, quality control and proficiency testing.

https://amp25.amp.org/program/special-scientific-events/reference-material-forum/

AMP 2025 graphic promotes the independent satellite symposium by Abbvie titled "Unlocking the Potential of c-Met: Targeting Protein Expression and Amplification in Solid Tumors." It'll be at 7 a.m. Thursday, Nov. 13, at the meeting in Boston.

🌅 Attention #AMPath2025 early birds:

AbbVie will host a symposium titled "Unlocking c-Met: Targeting Protein Expression & Amplification in Solid Tumors"

📅 Thu, Nov. 13 | 7 a.m. | Room 160ABC

More info: https://amp25.amp.org/program/special-scientific-events/independent-satellite-symposia/

Text on the left reads: New on our YouTube channel: Emerging and Evolving Biomarkers: Methylation Profiling with a link to AMP's YouTube page. To the right is the introductory slide from the webinar.

📣ICYMI: The Emerging and Evolving Biomarkers: Methylation Profiling webinar is available on YouTube!

Learn how DNA methylation profiling can be used to refine tumor classification schemes & as a clinical diagnostic for molecular tumor classification.

youtu.be/Sb3FaJu8hbg

Social card for webinar series presented by AMP titled "Metastatic Breast Cancer Molecular Testing." This card is promoting the first webinar in the series, "Molecular Testing Strategies and Evaluation of Assay Performance" featuring speakers Katherine B. Geiersbach and Shuko Harada.

TODAY is the 2nd webinar in our free series on concepts in molecular testing for HR+/HER- breast cancer. We’ll focus on evaluating assay performance in molecular laboratories for ESR1, PIK3CA, AKT1 & PTEN mutations in breast cancer
https://educate.amp.org/local/catalog/view/product.php?productid=577

Flyer advertising a new free webinar as part of the Association of Molecular Biology’s Emerging and Evolving Biomarkers series, titled “Cell-free DNA (cfDNA) from cerebrospinal fluid (CSF) for diagnosis and molecular testing of brain tumors.” The webinar is scheduled for 1 p.m. Eastern on October 9. On the left is a close-up image of a strand of DNA. On the right is a photograph of Tejus A. Bale, the webinar speaker, and Pawel Mroz, the webinar moderator. At the bottom of the image, the level of instruction for the webinar is labeled as intermediate and CME/CMLE credit of 1.0 is offered.

📣Webinar now available free and on demand:

Learn more about the use of cell-free DNA from cerebrospinal fluid for diagnosis and molecular testing of brain tumors.

Register: https://educate.amp.org/local/catalog/view/product.php?productid=583

Social card for webinar series presented by AMP titled "Metastatic Breast Cancer Molecular Testing." This card is promoting the third webinar in the series, "Applying Molecular Testing in Practice with Case Discussions and Expert Panel" featuring speaker Karthik Giridhar.

Oct. 30: the final webinar in our FREE series on concepts in molecular testing for HR+/HER- breast cancer, showing how specific genomic alterations (e.g., PIK3CA & ESR1 variants)can guide treatment strategies & improve outcomes.

https://educate.amp.org/local/catalog/view/product.php?productid=577

#ArticleinPress: Analysis of the Fragmentation and Integrity of Urine Cell-Free DNA as a Diagnostic and Staging Biomarker for Bladder Cancer.

Full text: https://www.jmdjournal.org/article/S1525-1578(25)00222-3/fulltext

#ArticleinPress: Validation and Clinical Utility of a Pan-Cancer Circulating Tumor DNA Assay as a First-Approach Test. Authors from @mayoclinic.org.

#OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(25)00221-1/fulltext

Graphic promoting the free webinar “From Variants to Value: The Expanding Role of Clinical Bioinformatics.” It features a headshot of the speaker, Srika Chamala, PhD (Children’s Hospital of Los Angeles, University of Southern California), and the moderator, Rebecca Yee, PhD (George Washington University). The webinar is scheduled for September 30 at 1 p.m. Eastern.

📣Webinar now on demand:

How does clinical bioinformatics turn genomic data into better care? 💡

Find out at our webinar with Srika Chamala.

https://educate.amp.org/local/catalog/view/product.php?productid=582

Free for AMP members. Just $29 for all others.

Social card for webinar series presented by AMP titled "Metastatic Breast Cancer Molecular Testing." This card is promoting the first webinar in the series, "Molecular Testing Strategies and Evaluation of Assay Performance" featuring speakers Katherine B. Geiersbach and Shuko Harada.

Oct. 27 is the second webinar in our free series on concepts in molecular testing for HR+/HER- breast cancer, focused on evaluating assay performance in molecular laboratories for ESR1, PIK3CA, AKT1& PTEN mutations in breast cancer
https://educate.amp.org/local/catalog/view/product.php?productid=577

The newest AMP case report in CAP Today examines two cases of BTK resistance mutations with “two different, independently arising clonal populations.”

Learn more by reading this case report, “Unique patterns of BTK resistance.”

https://www.amp.org/clinical-practice/amp-case-reports-in-cap-today/

Graphic announcing a clinical practice update open comment period for guideline updates on the interpretation and reporting of sequence variants in cancer. Comments are due by February 28.

AMP convened a working group to identify literature describing the current state of clinical NGS testing practices for evaluating B-cell and/or T-cell lymphoid clonality.

To see the group's draft recommendations and submit comments, visit: https://www.amp.org/clinical-practice/open-public-comment/

If you haven’t already, make sure to check out our newly updated Molecular in My Pocket™ cards!

The collection of quick reference guides is for everyone, from trainees to experienced professionals, seeking concise molecular diagnostics information.

https://www.amp.org/MIMP

Survey of Demographics, Training, Duties, and Professional Development for Variant Scientists in Genomic Medicine.

#OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(25)00169-2/fulltext

#LegacyContent: Strategic Implementation of #FragileX Carrier Screening in China: A Focused Pilot Study.

Free in the #OpenArchive: https://www.jmdjournal.org/article/S1525-1578(24)00156-9/fulltext

Bangs Labs is getting ⚡ lit up ⚡with excitement to attend the AMP 2025 Annual Meeting & Expo on November 11-15! Meet us in Boston at booth #535.

View #AMPath2025 details: amp25.amp.org
@ampath.bsky.social

Social card for webinar series presented by AMP titled "Metastatic Breast Cancer Molecular Testing." This card is promoting the first webinar in the series, "Introduction to Molecular Biomarkers: Evidence and Guidelines" featuring speakers Eric Vail and Paul M. Waring.

Join us today at 4 p.m. Eastern for the first webinar in our FREE series on current concepts in molecular testing for HR+/HER- breast cancer. Today’s session will focus on PI3K pathway and ESR1 mutations in ER+ HER2- breast cancer.
https://educate.amp.org/local/catalog/view/product.php?productid=577

📣UPDATE: The #AMPath2025 registration deadline has been extended to tomorrow, Tuesday, Oct. 21 at 11:59 p.m. Eastern.

Register by tomorrow night to save on your registration fee!

https://amp25.amp.org/registration/registration-rates-policies-and-target-audience/

Graphic shows Boston skyline under AMP2025 Annual Meeting & Expo logo. The dates of the meeting are listed as November 11 to 15, and the location of the meeting is listed as Boston. At the bottom, it says, "Register now for the premier meeting for molecular professionals." Under that text is a link to the AMP2025 website (amp25.amp.org).

Register TODAY for #AMPath2025 now to save on your registration fee. The discount ends at 11:59 p.m. Eastern tonight (Oct. 20), so make sure to sign up now to save!

https://amp25.amp.org/registration/registration-rates-policies-and-target-audience/

Graphic advertising that GetAMPed! registration for AMP2025 is open through Wednesday, November 12. The event is located at the Omni Seaport Hotel in Boston, MA and can provide attendees CME/CMLE credit. At the bottom, it is noted that GetAMPed! can be added on to an AMP 2025 registration or purchased as an individual course.

Start #AMPath2025 strong with GetAMPed! on Nov. 12.

It's for pathologists, geneticists, lab professionals, trainees and others with a working knowledge of molecular techniques who want to deepen their practical understanding.

Info: https://amp25.amp.org/program/special-scientific-events/get-amped/

#ArticleinPress: TAG-CLL, a Novel Tagmentation-Based Approach to Somatic Hypermutation Testing of IGHV Reveals the Weak Points of Both Sanger and Next-Generation Sequencing Methods. @polskaakademianauk.bsky.social

Full text: https://loom.ly/5YyF7cQ

Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations.

Full text: https://www.jmdjournal.org/article/S1525-1578(25)00170-9/fulltext

For October, the ASIP calendar features The Journal of Molecular Diagnostics! @jmdiagn.bsky.social is the official publication of @ampath.bsky.social, co-owned by the ASIP https://www.jmdjournal.org #MolecularDiscoveries

Seeking concise molecular diagnostics information? We’re excited to announce that our Molecular in My Pocket™ cards have been newly updated for 2025!

Print them out to have on hand in your workspace or download them to your phone for on-the-go access!

https://www.amp.org/MIMP

Announcement of the AMP online corporate workshop "NGS applications: Assessing clonality and diversity" on October 16 at 1 p.m. Eastern. Headshots of the two speakers, Rebecca Ramesh and Jeremiah X. Karrs, are featured.

TODAY:
See how new DNA sequencing methods are improving the way we study immune cells & detect blood cancers. Our webinar will include real-life examples, showing how these new tests can become part of everyday lab work
https://us06web.zoom.us/webinar/register/WN_8g4hi-I8QaqfTMCGiqrrbQ#/registration

📣Monday, Oct. 20, is the last day to save on registration for #AMPath2025!

🧐See the program: https://amp25.amp.org/program/amp-2025-program/

🥳Register: https://amp25.amp.org/registration/registration-rates-policies-and-target-audience/

Hear from #AMPath2025 plenary speaker Heidi Rehm, Ph.D., about the #molpath field's efforts to address challenges with identifying and reporting variants of uncertain significance (VUS) during germline genetic testing.

🔎 View details: https://amp25.amp.org/program/amp-2025-program/

Two AMP staffers and AMP President Jane Gibson on Capitol Hill.

Last week AMP staffers and President Jane Gibson were on Capitol Hill to express their concerns regarding the Patent Eligibility Restoration Act.

To learn more about AMP’s stance, visit:
https://www.amp.org/advocacy/take-action

(Pictured: Two AMP staffers alongside AMP President Jane Gibson)